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Steroid receptors are pleiotropic transcription factors that co-
ordinate adaptation to different physiological states. An impor-
tant target organ is the brain, but even though their effects are
well studied in specific regions, brain-wide steroid receptor targets
and mediators remain largely unknown due to the complexity of
the brain. Here, we tested the idea that novel aspects of steroid
action can be identified through spatial correlation of steroid re-
ceptors with genome-wide mRNA expression across different re-
gions in the mouse brain. First, we observed significant coexpression
of six nuclear receptors (NRs) [androgen receptor (Ar), estrogen re-
ceptor alpha (Esr1), estrogen receptor beta (Esr2), glucocorticoid
receptor (Gr), mineralocorticoid receptor (Mr), and progesterone
receptor (Pgr)] with sets of steroid target genes that were identi-
fied in single brain regions. These coexpression relationships were
also present in distinct other brain regions, suggestive of as yet un-
identified coordinate regulation of brain regions by, for example,
glucocorticoids and estrogens. Second, coexpression of a set of 62
known NR coregulators and the six steroid receptors in 12 non-
overlapping mouse brain regions revealed selective downstream
pathways, such as Pak6 as a mediator for the effects ofAr andGr on
dopaminergic transmission. Third, Magel2 and Irs4 were identified
and validated as strongly responsive targets to the estrogen dieth-
ylstilbestrol in themouse hypothalamus. The brain- and genome-wide
correlations of mRNA expression levels of six steroid receptors that
we provide constitute a rich resource for further predictions and un-
derstanding of brain modulation by steroid hormones.
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Steroid receptors are part of the superfamily of nuclear re-ceptors (NRs) that act as transcription factors regulating
expression of numerous biologically important target genes (1).
Their transcriptional activity is induced by steroid hormones,
which respond to changed demands in terms of reproductive
status, mineral balance, or stressful physical and psychological
challenges. A crucial site of action is the brain, where these
hormones have strong modulatory effects on physiological reg-
ulation, cognitive function, mood, and behavior. They do so by
changing cellular responsiveness to a variety of neurotransmit-
ters and peptides, and by inducing morphological changes (2, 3).
Understanding the effects of steroid hormones on the brain
faces the challenge to identify in as many as 900 different brain
nuclei (4) both the highly cell-specific target genes that mediate
the hormone effects (5, 6) and the signaling factors that me-
diate or influence steroid receptor signaling. The latter include
proteins affecting prereceptor metabolism, interacting tran-
scription factors (7), and downstream NR coregulator proteins
(1). Even if the effects of steroid hormones are well-studied in
specific regions (1, 8), overall, the brain steroid receptor targets
and mediators remain largely unknown.
In situ hybridization (ISH) has been used to identify the
functional roles of the 49 NR genes in adult mouse brain based
on the clustering of the NR expression patterns in anatomical
and regulatory networks (9). In this study, we substantially ex-
tended this approach to identify targets and signaling partners of
the steroid receptors, and relationships between different regions
of the mouse brain, based on genome-wide coexpression with
steroid receptors. The Allen Brain Atlas (ABA) (4) is the most
comprehensive repository of ISH-based gene expression in the
adult mouse brain. We used the ABA to identify genes that have
3D spatial gene expression profiles similar to steroid receptors.
To validate the functional relevance of this approach, we ana-
lyzed the coexpression relationship of the glucocorticoid receptor
(Gr) and estrogen receptor alpha (Esr1) and their known tran-
scriptional targets in specific brain regions. We then exploited these
associations to derive hypotheses about the functional role of re-
ceptors in brain regions with no previously known effects of ste-
roids. Furthermore, we studied the region-specific coexpression of
NRs and their downstream mediators (coregulators) to identify
specific partners mediating the hormonal effects on dopaminergic
transmission. Finally, to illustrate the potential of using spatial
coexpression to predict region-specific steroid receptor targets
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in the brain, we identified and validated genes that responded
to changes in estrogen in the mouse hypothalamus (HY).
Results
Spatial Expression Reveals Known Sites of Action of Steroid Receptors
in the Mouse Brain. We first analyzed the mRNA expression of six
nuclear steroid receptors [Esr1 and estrogen receptor beta (Esr2),
androgen receptor (Ar), progesterone receptor (Pgr), Gr, and min-
eralocorticoid receptor (Mr)] across the brain using the 3D spatial
gene expression data from the ABA (4). We generated a general
overview of the expression of each receptor across 12 nonoverlapping
brain structures covering the entire brain: isocortex; olfactory areas
(OLF), hippocampal formation, cortical subplate, striatum (STR),
pallidum (PAL), cerebellum, thalamus (TH), HY, midbrain (MB),
pons, and medulla (Fig. 1A). The expression profiles generally cor-
respond to the known distribution and sites of action of different
receptors (9), and provide comprehensive information at the higher
aggregation level of brain regions described here. For example, Esr1
is highly expressed in the HY, OLF, and cortical subpalate. Within
the HY, Esr1 shows high expression in the arcuate hypothalamic
nucleus (ARH), and medial preoptic nucleus (MPO) (Fig. 1B).Gr is
highly expressed in the cornu ammonis subdivision 1 (CA1) and
dentate gyrus (DG) areas of the hippocampus, cortex, and TH,
whereas Mr is predominantly expressed in the hippocampus (Fig.
1A). These expression patterns are well in line with the known sites of
action of the different receptors across the brain (10, 11).
Genes Spatially Coexpressed with Steroid Receptors Indicate Regional
Functional Specificity. To go beyond the expression profiles of ste-
roid receptors as reported in the literature, we identified genes
with similar expression profiles to each of the receptors. Based
on the principle of “guilt by association,” these coexpressed genes
are likely to be enriched in receptor target genes and receptor
signaling partners such as coregulators. For each steroid re-
ceptor, we ranked genes based on their spatial coexpression
across the whole brain as well as in each of the aforementioned
12 brain structures separately, resulting in 13 ranked lists per re-
ceptor (Dataset S1). (Datasets S1–S6 are available at data.3tu.nl/
repository/uuid:ecc3b182-d312-4216-9053-a824d0e04d5e.) For
each steroid receptor, strongly coexpressed genes within a brain
region are likely related to the localized functional role of the
receptor. For example, of the top 10 genes coexpressed with Esr1
across the whole brain, four were previously shown to be regu-
lated by ESR1 and/or estrogens in various tissues (Gpr101, Calcr,
Ngb, and Gpx3) (12–15). These genes were also coexpressed with
Esr1 in the HY, in line with their functional relationship to Esr1 in
mediating, for example, reproductive and metabolic processes.
However, whole-brain correlation of these genes with Esr1 was
also driven by the TH, MB, and PAL, demonstrating less obvious
relationships between Esr1 and these target genes. Strikingly,
among the top 10 genes coexpressed with Gr across the whole
brain, none are strongly coexpressed with Gr in the HY, indi-
cating that Gr signaling in the HY is rather distinct from Gr
signaling in the cortex, STR, TH, and MB.
In addition, we analyzed the functional enrichment of genes
coexpressed with Gr and Esr1 in the 12 brain regions (Table S1).
Esr1-coexpressed genes were enriched for neuropeptide regulation
in the HY as well as the cerebellum. A number of Gr-associated
genes in the HY were related to glia and oligodendrocyte devel-
opment, supporting the known effects of Gr on these processes in
the HY (16).
Glucocorticoid-Responsive Genes Are Highly Expressed with Gr in HP,
Pons, MB, and Whole Brain. To test the validity of our hypothesis
that coexpressed genes constitute candidate targets of steroid
receptors, we assessed the extent of coexpression between Gr
and known GR target genes. Because Gr has an important role
in mediating transcription of genes involved in coping with stress
within the hippocampus (2), we analyzed the coexpression of
glucocorticoid (GC)-responsive genes (i.e., likely GR targets)
with Gr in the whole brain and hippocampus, and in its
substructures, such as the DG and the different subregions of the
CA (Fig. 2A and Dataset S2). The set of GC-responsive genes we
considered originates from experiments where male rats were
exposed to GC treatment in a chronic restraint stress (CRS) con-
dition as well as in a control situation (17). These experiments
resulted in three sets of genes differentially expressed in DG neu-
rons: (i) GC-responsive genes in CRS rats, (ii) GC-responsive genes
in control rats, and (iii) genes that show differential expression in
GC treatment for both conditions (common GC-responsive genes).
As expected, GC-responsive genes are significantly coexpressed
with Gr in the DG (where they were identified) but, interestingly,
also in the whole brain and in the CA3 region [false discovery rate
(FDR)-corrected P < 1.8 × 10−3; Mann–Whitney U test]. The sig-
nificant coexpression of GC-responsive genes in the CA3 area in-
dicates that those cells in CA3 that do express Gr (10) may be
functionally linked to DG granule cells in terms of their response to
GCs. Of note, only those genes that responded to GC treatment in
stressed and control rats (common GC-responsive genes) showed a
significant coexpression with Gr in the DG, CA1, and (very sub-
stantially) CA3 regions of the hippocampus. The data reveal that
only the subset of invariant, context-independent GR target genes is
related to constitutive coexpression with Gr, even if the correlation
data come from “control” conditions.
The coexpression of the GC-responsive gene sets with Gr was not
significant for areas such as the HY and the cortex. We initially
considered these negative control regions, given that the target genes
were identified in microdissected DG granule neurons (17) and the
presumed high degree of cell specificity. However, the coexpression
ofGr with GC-responsive genes in CA3 prompted us to test whether
this coexpression also occurs in other brain areas. Fig. 2B shows that
the set of common GC-responsive genes is not only coexpressed with
Fig. 1. Expression of steroid receptors in the mouse brain. (A) Expression of six
steroid receptors across the 12 brain regions. Reported values are the average
expression energy per region normalized to the average expression across the
whole brain and then log2-transformed. (B) Example sagittal sections from the
Allen Brain Atlas (4) showing the ISH (Left), expression mask (Middle), and cor-
responding atlas section (Right) of Esr1 in the HY (Top) and Gr in the hippo-
campus (Bottom). Red arrows indicate the MPO, ARH, CA1, and DG.
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Gr in the hippocampus (DG, CA1, and CA3) but also in the cortical
subplate, PAL, and MB. These associations indicate a potential,
as yet unknown, relationship between these three brain areas in
terms of endocrine regulation, in accordance with the notion that
the cellular responses to GCs can be similar in distributed parts
of brain networks (18). Taken together, these results show that
GR targets are coexpressed with Gr in the DG, the region where
responsiveness was measured, as well as pointing to other brain
regions that might share the same regulation mechanism.
Sexually Dimorphic Genes Are Highly Coexpressed with Esr1 in the HY.
To illustrate the generalizability of our approach to other re-
ceptors and brain regions, we followed the same approach to
analyze the coexpression of Esr1 and its putative targets. Xu
et al. (19) showed that a set of 16 genes, including Esr1, has
sexual dimorphic expression in the adult mouse HY. In addition,
they showed that these 16 genes are sensitive to gonadal steroids
(also in the male mouse brain) and that some are necessary for
effects of estrogens on sexually dimorphic behavior (19), making
this set of ESR1 targets in the HY quite valuable.
Table S2 shows the correlation values for each of the 15 sexually
dimorphic genes with Esr1 in whole brain, as well as in the HY,
based on data from the ABA. The set of 15 genes is significantly
correlated to Esr1 based on whole-brain analysis (FDR-corrected
P = 8.69 ×10−14, Mann–Whitney U test) as well as the hypothalamic
expression pattern (P = 3.85 × 10−10). To test whether the correlation
between the 15 genes and Esr1 is HY-specific, we repeated the
analysis for all 12 brain structures. Fig. 3A shows that sexually di-
morphic genes are mostly correlated toEsr1 in the HY, PAL, TH, and
STR (P < 10−6). Similar to the results obtained for GR target genes,
we observed high coexpression outside the main region of action (e.g.,
in the PAL), suggesting that these brain regions share aspects of their
transcriptional response to estrogen receptor activation. Furthermore,
sex steroid receptors (Esr1, Esr2, and Pgr) showed higher coexpression
levels with the sexually dimorphic genes with respect to the stress ste-
roid-relatedMr andGr in theHY (Fig. 3B). The strongest coexpression
was with Esr1, indicating that the hypothalamic sexual dimorphism
genes are mainly, but probably not exclusively, related to Esr1. Taken
together, these results show that spatial coexpression can pinpoint
context-specific actions of steroid receptors (in this case, Gr and Esr1)
and yields region-specific coexpressed genes, a very rich resource with
which to generate hypotheses about steroid receptor targets.
Region-Specific Coregulator Analysis Points to Dopaminergic Transmission
via Pak6.So far, we have analyzed the potential of genes coexpressed
with receptors to include region-specific targets. However, because
correlation only indicates association rather than causation, coex-
pressed genes can also include coregulators of steroid receptors.
Previous studies have shown the signaling pathways of steroid re-
ceptors to differ across brain regions in a gene-specific manner
(1, 20). To identify putative region-dependent coregulators of ste-
roid receptors, we analyzed the coexpression relationships of each
steroid receptor and a set of 62 NR coregulators as present on a
peptide array (21) (complete data are provided in Dataset S3). Fig.
4A shows that the expression of coregulators varies greatly across
the different brain regions. For example, although Ncoa1 is
expressed in a fairly homogeneous manner, conforming to earlier
results (20),Ncoa4 is substantially enriched in the caudal brain regions.
The coexpressions of coregulators with the Ar, Gr, and Mr
differ greatly across different brain regions, indicating selective
coregulation (Fig. 4 B–D). For example, the AR/GR coactivators
Pias2 (22) and Ncoa4 (23) are highly coexpressed with Gr in the
MB and HY, respectively (Fig. 4C). However, both coactivators
are not coexpressed with Ar within the same regions even though
the relative abundance of Ar in the MB and the HY is higher
than Gr (Fig. 1A). Mr is predominantly expressed in the
A
B
Fig. 2. Coexpression of GC-responsive genes and Gr in the hippocampus.
(A) Coexpression of four GC-responsive gene sets with Gr in the whole brain,
hippocampus, DG, CA1, CA2, and CA3. (B) Coexpression of four GC-responsive
gene sets with Gr across the whole brain, as well as the 12 major brain
structures. All bars indicate the −log10 of the Wilcoxon rank sum test, and
the dashed line indicates the significance level at P = 0.05.
A
B
Fig. 3. Coexpression of sexually dimorphic genes and Esr1 in the HY.
(A) Coexpression of 15 sexually dimorphic genes with Esr1 across the mouse
brain. (B) Coexpression of the 15 sexually dimorphic genes with the six ste-
roid receptors across the whole brain, as well as the HY. All bars indicate
the −log10 of the Wilcoxon rank sum test, and the dashed line indicates the
significance level at P = 0.05.
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hippocampus, where it is highly coexpressed with Ncoa1, Txnrd1,
Trefl, Ncor1, Wipi1, and Ncor2 (Fig. 4D). Although Ncoa1 is a
known MR coregulator (24), little is known about the effect of
the other coregulators on MR function in the hippocampus, and
they might be good candidates for further functional analysis.
Because there still is substantial heterogeneity across the 12 brain
regions that we initially analyzed, we narrowed down our analysis to
well-established target regions of steroid hormone action. We ana-
lyzed the coexpression of the 62 coregulators with the steroid re-
ceptors in dopaminergic regions in the ventral tegmental area (VTA)
and substantia nigra (SN), which are known targets of steroid actions
(25, 26) (Figs. S1 and S2). We found three significantly coexpressed
coregulators with Ar in VTA/SN: Pnrc2, Pak6, and Trerf1 (Fig. 4E
and Dataset S4), suggesting that these coregulators may be involved
in mediating AR effects on dopaminergic transmission. Furthermore,
only Pak6 was strongly coexpressed with Gr in the dopaminergic
regions (P < 0.01). Thus, AR and GR may share some, but not
all, coregulators, much like the fact that AR binding sites may
overlap, in part, with GR binding sites (27). These results in-
dicate that we can use genome-wide spatial coexpression not
only to analyze the relationship between the receptors and their
targets but also to identify region-specific coregulators.
Predictive Value of Coexpression for Hormone Responsiveness: Magel2
Is Likely a Target of ESR1. Finally, we set out to test the predictive value
of high coexpression with a steroid receptor to identify transcriptional
targets. We measured the response of genes that are highly coex-
pressed with Esr1 in the HY to estrogen diethylstilbestrol (DES) in
castrated male mice using quantitative PCR (qPCR) (SI Materials and
Methods). In the male brain, testosterone can be metabolized to es-
trogen or act directly via the AR. To avoid interpretation difficulties,
we decided to activate brain estrogen receptors directly with the se-
lective ligand DES. We selected the top 10 most strongly coexpressed
genes with Esr1 in the HY. As a negative control, we used the set of
genes that are not coexpressed with Esr1 in the HY. Fig. 5A shows
examples, from the ISH experiments of the ABA, of Irs4 andMagel2,
two of the strongly coexpressed genes selected for validation.
Because Esr1 is not homogeneously expressed across the HY
(Fig. 1B), we analyzed the responsiveness of the set of top 10
genes to DES in the anterior (MPO) and posterior (ARH) parts
of the HY separately. Fold-change up-regulation was modest,
which may be due to nonresponsiveness, a modest transcriptional
response of brain targets, or dilution of the signal in the hypo-
thalamic homogenates (Table S3).
To confirm colocalization further, we performed quantitative
double ISH (dISH) for Esr1 and the six mRNAs (Irs4, Magel2,
Adck4, Unc5, Ngb, and Gdpd2) that showed more than 1.3-fold
enrichment in qPCR. Esr1 mRNA was consistently down-regulated
more than twofold upon DES treatment, validating the treatment
(Fig. S3). Irs4 and Magel2 mRNA were both significantly up-regu-
lated by DES treatment in MPO (1.9-fold and 2.4-fold, respectively),
whereas only Magel2 was up-regulated in ARH (2.6-fold) (Fig. 5 B
and D). A 1.3-fold induction of Ngb mRNA in ARH did not reach
statistical significance, whereas Gdpd2, Unc5d, and Adck4 mRNA
levels showed no trend of regulation after DES treatment (Fig. S4).
The data indicate that additional criteria are necessary for
reliable target prediction. Because Irs4 and Magel2 are among
the top genes expressed in the HY (ranked 1 and 11, re-
spectively) compared with a ranking of 141 for Adck4 and 284 for
Unc5d, these criteria may include a combination of expression,
coexpression filters, and other criteria.
Identifying GR-Related Corticosterone Targets in the Hippocampus.
Using gene expression measurements (qPCR and dISH), we vali-
dated the responsiveness of Irs4 and Magel2 as predicted ESR1
targets to DES treatment. Despite its importance, especially in
detecting colocalization, gene expression remains an indirect mea-
surement of interaction. Therefore, we set out to detect genomic
binding of steroid receptors directly using chromatin immunopre-
cipitation followed by next-generation sequencing (ChIP-Seq).
Previously, we used ChIP-Seq to identify genomic binding sites of
GR in the rat hippocampus (28). Reanalyzing this data, we iden-
tified 694 corticosterone target genes with GR binding sites, of
which 16 were within the top 200 genes coexpressed with Gr in the
hippocampus (16 of 200; P = 9.97 × 10−5, one-sided Fisher’s exact
test; Table S4). Fig. S5 shows examples of the GR binding sites we
identified in genes strongly coexpressed with Gr. We did not ob-
serve any significant enrichment of corticosterone target genes in
the 200 genes with the lowest correlation to Gr in the hippo-
campus (five of 200; P = 0.62, one-sided Fisher’s exact test) or in
the set of 200 genes with the highest correlation to Esr1 in the
hippocampus (one of 200; P = 1, one-sided Fisher’s exact test).
B C D EA
Fig. 4. Coexpression of coregulators and steroid
receptors. (A) Expression of 62 coregulators in 12
brain regions. Reported values are the average ex-
pression energy per region normalized to the average
expression across the whole brain and then log2-
transformed. Coexpression ranks of the 62 cor-
egulators with Ar (B), Gr (C ), and Mr (D). Dark red
corresponds to high rank (i.e., strong coexpression).
(E) Rank sum of the coexpression rank of each cor-
egulator with Ar in the dopaminergic regions (VTA
and SN).
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Discussion
Because nuclear steroid receptors act as transcription factors, they
may be expected a priori to coexpress with their target genes and
signaling partners. In the brain, the effects of steroid receptors are
region-specific, and by analyzing their spatial coexpression relation-
ships across different brain regions, we can define potential targets
and partners, as well as parallels between brain areas. The complexity
and large variability in gene expression across the brain have forced
many studies to analyze either brain-wide expression of a small set of
genes or genome-wide expression in a few regions. The availability of
high-resolution ISH-based expression maps of the mouse brain in the
ABA allows the identification of all genes with a similar expression
pattern across many brain regions that might indicate functional
similarity between the gene products (29). We provide a compre-
hensive description of the coexpression of genes with six receptors of
gonadal and adrenal steroid hormones in the male mouse brain. Our
results demonstrate that genes that are spatially coexpressed with
receptors in a region-specific manner can enhance our understanding
of brain modulation by steroid hormones.
Using genome-wide spatial coexpression analysis, we observed
strong coexpression of known GR transcriptional targets in the
hippocampus and known ESR1 transcriptional targets in the HY.
These observations support our hypothesis that genes showing
strong coexpression with a steroid receptor are enriched in tran-
scriptional targets and/or coregulators of that receptor. In addi-
tion, the unanticipated coexpression of genes with these receptors
outside their known sites of action may extend our understanding
of the coordinated steroid response of the brain. For example, the
high coexpression between Gr and its GC-responsive target genes
(originally derived from the DG) in CA3, the MB, and the PAL is
in line with a network that has been referred to as the neuro-
circuitry of stress (30). Likewise, dendritic complexity of neurons
and excitability are modulated by GCs and stress across different
brain regions simultaneously (18). Such similar responses of dis-
tinct brain regions suggest similar cellular machinery, and thus
similarly correlated gene expression with the responsible receptor.
For the genes that are expressed in a sex-specific manner, we
confirmed their coexpression with Esr1, Esr2, and Pgr, which is in
accordance with their regulation by gonadal steroids (19). Lack of
coexpression with Ar may reflect the fact that many testosterone
effects on the HY are mediated by estrogen receptors after aro-
matization of testosterone into estradiol. It is as yet unclear
whether the significant coexpression with Pgr reflects simply
coexpression of Esr1 and Pgr or also points to progesterone reg-
ulation of these genes. Regardless, we extended the coexpression
between sexually dimorphic genes to extrahypothalamic sites,
pointing to a parallel regulation in, at least, the PAL, a region that
includes the bed nucleus of the stria terminalis, where regulation
by (nonspecified) gonadal hormones has been observed (19).
Our analysis of the coexpression of coregulators and steroid
receptors identified known relationships, such as the high coex-
pression between Ncoa1 and Mr in the hippocampus (20). More
importantly, this brain-wide analysis provides an overview of
potentially unknown relationships between steroid receptors and
coregulators. By focusing on dopaminergic regions (VTA and
SN), we identified strong coexpression of Pak6 with Ar as well as
Gr. Of interest, Pak6 is a known AR coregulator (31) and Pak6
KO mice show several locomotion and behavioral deficits that
are likely related to disturbed dopaminergic transmission (32).
Thus, this example of Pak6 coexpression underscores the feasi-
bility of our methodology to find potential partners of nuclear
steroid receptors. Of note, steroid receptor/coactivator interac-
tions may be induced with a certain degree of specificity by se-
lective modulator types of steroid receptor ligands (24, 33). The
coexpression of steroid receptors with their coactivators may not
only predict steroid responsiveness but also point to selective
activation of particular circuits with synthetic ligands (24).
To test whether spatial coexpression can be used to predict
transcriptional targets of steroid receptors in the brain, we used
qPCR and dISH to assess if genes strongly coexpressed with Esr1 in
the HY include any ESR1 targets. Among the tested genes we
identified two estrogen-regulated genes: Irs4, a previously known
ESR1 target (19); and Magel2, a previously unidentified ESR1
target. Loss of Magel2 leads to impaired reproduction, providing
an immediate link to estrogen regulation (34). This gene is deleted
in Prader–Willi syndrome, which is associated with hypogonado-
tropic hypogonadism, obesity, and hyperphagia (35). Likewise, Irs4
has a role in hypothalamic leptin signaling and regulation of me-
tabolism (36). Therefore, hypothalamic estrogen responsiveness of
Magel2 and Irs4 may be related to estrogen effects on metabolism
(37). The presently modest predictive power may be improved by
incorporating the effect size (i.e., the absolute expression of a
gene), given the values for true positives Irs4 andMagel2. Also, the
presence of conserved steroid response elements on the DNA
could be a useful additional filter (38).
The enrichment of known targets and coregulators of a
certain NR within the same brain regions where the NR is
Fig. 5. Highly coexpressed genes are potential steroid targets. (A) Coronal ISH
sections showing the expression of Esr1, Irs4, and Magel2. (Scale bars, 600 μm.)
Data taken from the Allen Brain Atlas (4). Response of Irs4 (B) andMagel2 (C) to
DES treatment in castrated mice in theMPO and ARH using dISH. (D) dISH of Esr1
(red) and Irs4 (green) in the anterior HY. (Scale bars, 10 μm.Magnification, 100×.)
(E ) dISH of Esr1 (red) and Magel2 (green) in the anterior HY. (Scale bars,
10 μm. Magnification, 100×.) mRNA expression in ISH was quantified as the
percentage of the image surface with positive signal. Reported P values
are calculated with a one-sided, two-sample t test with a significant level
at P < 0.05.
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expressed confirms the validity of our analysis. Our approach is
even strengthened by the notion that the receptor and its targets
and/or coregulators are significantly coexpressed despite the
genome-wide and brain-wide qualitative approach of measuring
mRNA levels using ISH. However, there are some intrinsic limi-
tations to the analysis. First, although the quality of ISH is overall
high, it is insufficient for some genes. Of the three datasets cov-
ering expression of Gr, only one was of sufficient quality. Also,
Ncoa1, which codes for an important coregulator for ESR1 and
GR (1, 20), is expressed at low levels and not significantly asso-
ciated with the two receptors. Consequently, there is the risk for
increased false-negative results associated with a genome-wide
approach using these data. Second, the ABA maps the expression
of all genes under the same normal conditions. This dataset, al-
though unique in its brain-wide and genome-wide coverage, does
not include variations between individuals or context-specific ex-
pression patterns (SI Materials and Methods).
Our approach relies on Pearson’s correlation as a measure of
similarity between 3D expression patterns of genes, summarized to
200-μm isotropic voxels. Although using the expression volumes
instead of the original ISH slices simplifies computations and re-
duces noise effects, the lower resolution yields the analysis of small
brain nuclei unreliable. For example, the very small number of
voxels representing dorsal raphe nucleus in the 3D atlas hampered
analysis of the serotonergic dorsal raphe nucleus. By using
correlation as a measure of coexpression, we detect both direct
and indirect statistical associations between genes rather than
causal relationships, yielding functional validation using expres-
sion measurements (qPCR and/or dISH) and ChIP analysis
crucial to confirm predicted associations as well as causality.
Concluding, we have shown that nuclear steroid hormone re-
ceptors coexpress with genes not known to associate, and in brain
regions where steroids were not known to be active. These
findings point toward the brain region-specific signaling ma-
chinery of the steroid receptors.
Materials and Methods
SI Materials and Methods includes detailed descriptions of the ABA mouse
data, data preprocessing steps, spatial coexpression, gene set analysis,
selecting targets for experimental validation, rank sum analysis, qPCR vali-
dation, dISH, and the ChIP-Seq experiments.
All animal experiments were performed with the approval of the Animal
Ethics Committee at Erasmus Medical Center.
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